Skip to content
Review Open access

Radiographic progression patterns and treatment response in adult H3 K27-altered diffuse midline glioma: a descriptive review and single center case series

Oct 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 24 references
Medicine

TL;DR

Heterogeneity of adult H3 K27-altered DMG is highlighted and patterns of adult H3 K27-altered DMG in cases assessed at autopsy are described in cases assessed at autopsy.

Abstract

Background Diffuse midline glioma (DMG) with H3 K27 mutations are aggressive central nervous system tumors with limited treatment options and poor outcomes. Although more common in children, there is increasing recognition of adult cases, which remain under-characterized regarding longitudinal imaging trends and response to multimodal treatment. We aim to highlight heterogeneity and describe patterns of adult H3 K27-altered DMG in cases assessed at autopsy. Methods Patients were included in the study if they were ≥ 21 years of age, and had a confirmed diagnosis of DMG, H3 K27-altered. Manual segmentations of contrast enhancement (CE) on T1-weighted post-contrast imaging and hyperintense FLAIR regions were performed at each timepoint. CE ratios (CEvol/FLAIRvol) were calculated to characterize enhancing versus infiltrative tumor burden. Treatment timelines were retrospectively aligned with imaging timing to evaluate disease progression and therapy response. Results This case series included six patients with confirmed H3 K27-altered DMG. Longitudinal imaging data revealed radiographic heterogeneity between patients. Periods of FLAIR reduction were observed to occur around bevacizumab treatment. Mean CE ratios were lowest in Patients 5 and 1 (0.081 and 0.225 respectively), intermediate in Patient 4 (0.312), and highest in Patient 3 (0.668). ATRX-mutant cases (n, 2) had comparatively short overall survival of 26 and 164 days while ATRX-wild type cases (n, 4) survived 728-2,299 days. Conclusions Among our cohort, we observed two patients with ATRX mutations to have comparatively short survival periods. Findings highlight heterogeneity of adult H3 K27-altered DMG, and limitations of imaging-based modalities to track tumor progression.

Read PDF

Similar papers

Case report Open access Oct 2026

Adult Thalamic Diffuse Midline Glioma, H3 K27-Altered, With KRAS Comutation and Potential Early Subependymal Dissemination

The case of a 54-year-old adult patient with a left thalamic DMG, H3 K27-altered, World Health Organization (WHO) grade 4, harboring pathogenic H3F3A K27M, KRAS G12V, and PHF6 mutations is presented and the potential biological implications of a KRAS comutation in this rare entity are discussed.

Muralidhar Idamakanti, R. Bijjam, Yasvin Onkarappa Mangala · 0 citations
Open access Nov 2026

Case Report: Multimodal treatment of pediatric H3G34-mutant diffuse hemispheric glioma: a safety and feasibility case report combining precision medicine and tumor treating fields with conventional care

A case of a 13-year-old boy with H3G34-DHG who underwent a multimodal treatment strategy, combining backbone chemotherapy, radiotherapy, surgery, tumour treating fields with Wilms Tumour-1 (WT1) directed dendritic cell immunotherapy and targeted therapy (STAT3-inhibition) supports the feasibility of combining multiple...

Toon van Genechten, A. Claviez, S. Oberbeck et al. · 0 citations
Open access Oct 2026

Epilepsy in adult-type diffuse low-grade gliomas: clinical, imaging and surgical outcome evaluation

Background: Adult-type diffuse low-grade gliomas (LGGs) are frequently associated with epilepsy, which may represent the initial clinical manifestation and significantly impact patients’ quality of life. The relationship between extent of resection and postoperative seizure control remains a key issue in neuro-oncology...

L. Passarella, Enrico Ghizoni, C. Formentin et al. · 0 citations
Oct 2026

Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant Glioma.

BACKGROUND Contrast enhancement is generally considered an adverse prognostic feature in adult glioma. However, its significance in newly diagnosed grade 2 IDH-mutant glioma remains uncertain, with important implications for use of the mutant IDH inhibitor vorasidenib. We evaluated survival outcomes associated with pre...

Vihang Nakhate, Aleksandra B. Lasica, Loai Aker et al. · 0 citations
Open access Oct 2026

Intratumoral susceptibility signals in adult-type diffuse gliomas: associations with molecular profile, tumor grade, and overall survival

Purpose Intratumoral Susceptibility Signals (ITSS) are low-signal-intensity structures observed on susceptibility-weighted imaging (SWI) which may reflect intratumoral microhemorrhages, calcifications, and neovascularization. Previous studies have demonstrated associations between ITSS, glioma grade, and molecular char...

P. Feraco, D. Giuliani, G. Espa et al. · 0 citations
Oct 2026

Diffuse brainstem gliomas across the pediatric, adolescent, and adult age spectrum: Clinical and radiological features, molecular profile, and determinants of survival in a multicenter retrospective cohort of 42 patients

Background: Diffuse brainstem gliomas are infiltrative neoplasms classically described in children as diffuse intrinsic pontine glioma, but increasingly recognized in adults. We describe the clinical, radiological, molecular, and survival characteristics of a cohort spanning the full age spectrum and identify determina...

Andrea García-Bitar, G. A. Gutiérrez-Aceves, A. Rodríguez-Camacho et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.